{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:58:35Z","timestamp":1793059115308,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CGbio Inc\/BioAlpha Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study aimed to evaluate the mid-term efficacy and safety of <jats:italic>Escherichia coli<\/jats:italic>-derived bone morphogenetic protein-2 (E.BMP-2)\/hydroxyapatite (HA) in lumbar posterolateral fusion (PLF).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicenter, evaluator-blinded, observational study utilized prospectively collected clinical data. We enrolled 74 patients who underwent lumbar PLF and had previously participated in the BA06-CP01 clinical study, which compared the short-term outcomes of E.BMP-2 with an auto-iliac bone graft (AIBG). Radiographs and CT scans were analyzed to evaluate fusion grade at 12, 24, and 36\u00a0months. Visual analog scale (VAS), Oswestry disability index (ODI), and Short Form-36 (SF-36) scores were measured preoperatively and at 36\u00a0months after surgery. All adverse events in this study were assessed for its relationship with E.BMP-2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The fusion grade of the E.BMP-2 group (4.91\u2009\u00b1\u20090.41) was superior to that of the AIBG group (4.25\u2009\u00b1\u20091.26) in CT scans at 36\u00a0months after surgery (<jats:italic>p<\/jats:italic>\u2009=\u20090.007). Non-union cases were 4.3% in the E.BMP-2 and 16.7% in the AIBG. Both groups showed improvement in pain VAS, ODI, and SF-36 scores when compared to the baseline values, and there were no statistically significant differences between the two groups. No treatment-related serious adverse reactions were observed in either group. No neoplasm-related adverse events occurred in the E.BMP-2 group.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The fusion quality of E.BMP-2\/HA was superior to that of AIBG. E.BMP-2\/HA showed comparable mid-term outcomes to that of AIBG in terms of efficacy and safety in one-level lumbar PLF surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00586-022-07440-3","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T15:05:03Z","timestamp":1668697503000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mid-term efficacy and safety of Escherichia coli-derived rhBMP-2\/hydroxyapatite carrier in lumbar posterolateral fusion: a randomized, multicenter study"],"prefix":"10.1007","volume":"32","author":[{"given":"Minjoon","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KI-Han","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sup","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-0266","authenticated-orcid":false,"given":"Jae Hyup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"7440_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/01.BRS.0000119398.22620.92","volume":"29","author":"MB Kornblum","year":"2004","unstructured":"Kornblum MB, Fischgrund JS, Herkowitz HN, Abraham DA, Berkower DL, Ditkoff JS (2004) Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective long-term study comparing fusion and pseudarthrosis. Spine 29:726\u2013733","journal-title":"Spine"},{"key":"7440_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.31616\/asj.2020.0485","volume":"14","author":"Y-H Kim","year":"2020","unstructured":"Kim Y-H, Ha K-Y, Rhyu K-W, Park H-Y, Cho C-H, Kim H-C, Lee H-J, Kim S-I (2020) Lumbar interbody fusion: techniques pearls and pitfalls. Asian Spine J 14:730","journal-title":"Asian Spine J"},{"key":"7440_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/17453679309160140","volume":"64","author":"JA Turner","year":"1993","unstructured":"Turner JA, Herron L, Deyo RA (1993) Meta-analysis of the results of lumbar spine fusion. Acta Orthop Scand 64:120\u2013122","journal-title":"Acta Orthop Scand"},{"key":"7440_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00003086-199706000-00011","volume":"339","author":"JA Goulet","year":"1997","unstructured":"Goulet JA, Senunas LE, DeSilva GL, Greenfield MLV (1997) Autogenous iliac crest bone graft: complications and functional assessment. Clin Orthop Relat Res\u00ae 339:76\u201381","journal-title":"Clin Orthop Relat Res\u00ae"},{"key":"7440_CR5","first-page":"337","volume":"15","author":"JK Burkus","year":"2002","unstructured":"Burkus JK, Gornet MF, Dickman CA, Zdeblick TA (2002) Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. Clin Spine Surg 15:337\u2013349","journal-title":"Clin Spine Surg"},{"key":"7440_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/brs.0000000000000971","volume":"40","author":"F Galimberti","year":"2015","unstructured":"Galimberti F, Lubelski D, Healy AT, Wang T, Abdullah KG, Nowacki AS, Benzel EC, Mroz TE (2015) A systematic review of lumbar fusion rates with and without the use of rhBMP-2. Spine 40:1132\u20131139. https:\/\/doi.org\/10.1097\/brs.0000000000000971","journal-title":"Spine"},{"key":"7440_CR7","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/bit.26798","volume":"115","author":"CL Kim","year":"2018","unstructured":"Kim CL, Jung MY, Kim YS, Jang JW, Lee GM (2018) Improving the production of recombinant human bone morphogenetic protein-4 in Chinese hamster ovary cell cultures by inhibition of undesirable endocytosis. Biotechnol Bioeng 115:2565\u20132575. https:\/\/doi.org\/10.1002\/bit.26798","journal-title":"Biotechnol Bioeng"},{"key":"7440_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/08977194.2019.1596905","volume":"37","author":"Y-Z Jin","year":"2019","unstructured":"Jin Y-Z, Zheng G-B, Lee JH (2019) Escherichia coli BMP-2 showed comparable osteoinductivity with Chinese hamster ovary derived BMP-2 with demineralized bone matrix as carrier. Growth Factors 37:85\u201394","journal-title":"Growth Factors"},{"key":"7440_CR9","first-page":"8","volume":"8","author":"JH Lee","year":"2011","unstructured":"Lee JH, Jang S-J, Koo T-Y, Suh CW, Lee EN, Lee K-M, Lee HS, Baek H-R (2011) Expression, purification and osteogenic bioactivity of recombinant human BMP-2 derived by Escherichia coli. Tissue Eng Regen Med 8:8\u201315","journal-title":"Tissue Eng Regen Med"},{"key":"7440_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.spinee.2012.01.013","volume":"12","author":"JH Lee","year":"2012","unstructured":"Lee JH, Yu CH, Yang JJ, Baek H-R, Lee K-M, Koo T-Y, Chang B-S, Lee C-K (2012) Comparative study of fusion rate induced by different dosages of Escherichia coli\u2013derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J 12:239\u2013248","journal-title":"Spine J"},{"key":"7440_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/ten.TEA.2010.0408","volume":"17","author":"IS Kim","year":"2011","unstructured":"Kim IS, Lee EN, Cho TH, Song YM, Hwang SJ, Oh JH, Park EK, Koo TY, Seo YK (2011) Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. Tissue Eng Part A 17:337\u2013348. https:\/\/doi.org\/10.1089\/ten.TEA.2010.0408","journal-title":"Tissue Eng Part A"},{"key":"7440_CR12","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.spinee.2014.06.007","volume":"14","author":"C-B Kong","year":"2014","unstructured":"Kong C-B, Lee JH, Baek H-R, Lee C-K, Chang B-S (2014) Posterolateral lumbar fusion using Escherichia coli\u2013derived rhBMP-2\/hydroxyapatite in the mini pig. Spine J 14:2959\u20132967","journal-title":"Spine J"},{"key":"7440_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40824-021-00225-7","volume":"25","author":"Y-Z Jin","year":"2021","unstructured":"Jin Y-Z, Zheng G-B, Lee JH, Han S-H (2021) Comparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2. Biomater Res 25:1\u20137","journal-title":"Biomater Res"},{"key":"7440_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1600-0501.2010.01953.x","volume":"21","author":"DK Kim","year":"2010","unstructured":"Kim DK, Lee SJ, Cho TH, Hui P, Kwon MS, Hwang SJ (2010) Comparison of a synthetic bone substitute composed of carbonated apatite with an anorganic bovine xenograft in particulate forms in a canine maxillary augmentation model. Clin Oral Implant Res 21:1334\u20131344","journal-title":"Clin Oral Implant Res"},{"key":"7440_CR15","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.spinee.2017.06.023","volume":"17","author":"JH Cho","year":"2017","unstructured":"Cho JH, Lee JH, Yeom JS, Chang B-S, Yang JJ, Koo KH, Hwang CJ, Lee KB, Kim H-J, Lee C-K (2017) Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial. Spine J 17:1866\u20131874","journal-title":"Spine J"},{"key":"7440_CR16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1097\/01.brs.0000172157.39513.80","volume":"30","author":"SD Glassman","year":"2005","unstructured":"Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, Johnson JR (2005) Initial fusion rates with recombinant human bone morphogenetic protein-2\/compression resistant matrix and a hydroxyapatite and tricalcium phosphate\/collagen carrier in posterolateral spinal fusion. Spine 30:1694\u20131698","journal-title":"Spine"},{"issue":"8","key":"7440_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.spinee.2021.04.007","volume":"21","author":"HJ Son","year":"2021","unstructured":"Son HJ, Choi SH, Lee MK, Kang C-N (2021) Efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional lumbar posterolateral fusion: minimum 1 year follow-up. Spine J 21(8):1340\u20131346","journal-title":"Spine J"},{"key":"7440_CR18","first-page":"548","volume":"39","author":"JP Sheehan","year":"1996","unstructured":"Sheehan JP, Kallmes DF, Sheehan JM, Jane JA, Fergus AH, DiPierro CG, Simmons NE, Makel DD, Helm GA (1996) Molecular methods of enhancing lumbar spine fusion. Neurosurgery 39:548\u2013554","journal-title":"Neurosurgery"},{"key":"7440_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/01.BRS.0000048469.45035.B9","volume":"28","author":"JK Burkus","year":"2003","unstructured":"Burkus JK, Dorchak JD, Sanders DL (2003) Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 28:372\u2013377","journal-title":"Spine"},{"key":"7440_CR20","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1097\/BRS.0b013e31820bc9e5","volume":"36","author":"KS Cahill","year":"2011","unstructured":"Cahill KS, Chi JH, Groff MW, McGuire K, Afendulis CC, Claus EB (2011) Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein. Spine 36:2354","journal-title":"Spine"},{"key":"7440_CR21","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1097\/01.brs.0000240715.78657.81","volume":"31","author":"JR Dimar","year":"2006","unstructured":"Dimar JR, Glassman SD, Burkus KJ, Carreon LY (2006) Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2\/compression resistant matrix versus iliac crest bone graft. Spine 31:2534\u20132539","journal-title":"Spine"},{"key":"7440_CR22","doi-asserted-by":"publisher","first-page":"035","DOI":"10.1055\/s-0031-1298616","volume":"3","author":"JG DeVine","year":"2012","unstructured":"DeVine JG, Dettori JR, France JC, Brodt E, McGuire RA (2012) The use of rhBMP in spine surgery: is there a cancer risk? Evid-based spine-care J 3:035\u2013041","journal-title":"Evid-based spine-care J"},{"key":"7440_CR23","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2106\/JBJS.G.01157","volume":"91","author":"E Dawson","year":"2009","unstructured":"Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD (2009) Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation: a prospective randomized trial. JBJS 91:1604\u20131613","journal-title":"JBJS"},{"key":"7440_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/00007632-199906150-00002","volume":"24","author":"SD Boden","year":"1999","unstructured":"Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA (1999) Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2\/hydroxyapatite\u2013tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24:1179\u20131185","journal-title":"Spine"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-022-07440-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00586-022-07440-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-022-07440-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:38:31Z","timestamp":1674851911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00586-022-07440-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7440"],"URL":"https:\/\/doi.org\/10.1007\/s00586-022-07440-3","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"4 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MJC, KHY, JHC: Nothing to disclose. JHL, JSY, HMK, KBL, JHC, JJY: Grant:CG Bio\/BioAlpha Inc (Paid directly to institution), pertaining to the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}